Picture

Questions?

+1-866-353-3335

SEARCH
What are you looking for?
Need help finding what you are looking for? Contact Us
Compare

PUBLISHER: Acute Market Reports | PRODUCT CODE: 1422168

Cover Image

PUBLISHER: Acute Market Reports | PRODUCT CODE: 1422168

Equine Healthcare Market - Growth, Future Prospects and Competitive Analysis, 2023 - 2031

PUBLISHED:
PAGES: 118 Pages
DELIVERY TIME: 1-2 business days
SELECT AN OPTION
PDF (Single User License)
USD 4500
PDF (Multi User License)
USD 6500
PDF (Enterprise License)
USD 9000

Add to Cart

The equine healthcare market is expected to grow at a CAGR of 6.1% during the forecast period of 2024 to 2032, driven by key drivers such as preventive healthcare measures, advancements in diagnostics and treatment, and the rising focus on equine sports and recreation. However, challenges related to cost and accessibility pose constraints. Market segmentation underscores the dominance of specific product categories and indications, while geographic trends highlight regional variations in market dynamics. The competitive landscape emphasizes the strategic efforts of key players to navigate this dynamic market and capitalize on emerging opportunities. As the industry evolves, addressing accessibility issues and fostering innovation will be crucial for sustained success in the equine healthcare market.

Increasing Emphasis on Preventive Healthcare

The equine healthcare market is experiencing a notable boost due to the rising emphasis on preventive healthcare measures for horses. Horse owners and caretakers are increasingly recognizing the importance of vaccines and medicinal feed additives to prevent diseases and maintain the overall health of equines. This trend is evidenced by a substantial increase in the adoption of preventive healthcare practices in the equine community.

Advancements in Diagnostics and Treatment

Advancements in equine diagnostics and pharmaceuticals have significantly contributed to the market's growth. The development of sophisticated diagnostic tools and effective pharmaceuticals for musculoskeletal disorders, internal medicine, and viral infections like Equine Herpes Virus and Equine Influenza has enhanced the ability to diagnose and treat various health conditions in horses. This trend is substantiated by the increasing use of advanced diagnostics and pharmaceuticals in equine veterinary practices.

Rising Focus on Equine Sports and Recreation

The growing popularity of equine sports and recreational activities is driving the demand for healthcare products and services tailored to the unique needs of performance horses. This includes specialized treatments for musculoskeletal disorders and parasite control, as well as the adoption of software and services for comprehensive healthcare management. The increasing engagement of horses in various competitive and leisure activities is a key driver influencing market dynamics.

Market Restraint

Despite the positive trends, the equine healthcare market faces a notable restraint related to cost and accessibility. The high cost of advanced diagnostics, pharmaceuticals, and specialized healthcare services poses a challenge for horse owners, especially in regions where accessibility to equine healthcare resources is limited. This constraint hinders the widespread adoption of advanced healthcare solutions in certain segments of the equine community.

Market Analysis by Product: Pharmaceuticals Dominate the Market

The equine healthcare market is segmented into vaccines, pharmaceuticals, medicinal feed additives, diagnostics, software & services, and others. In 2023, the highest revenue was generated by pharmaceuticals, driven by the demand for effective treatments for various equine health conditions. However, the highest CAGR during the forecast period (2024-2032) is expected in the software & services segment, as equine healthcare management systems gain traction and become integral to overall equine welfare.

Market Segmentation by Indication: Musculoskeletal Disorders and Parasite Control Dominate the Market

The indication-based segmentation includes musculoskeletal disorders, parasite control, internal medicine, Equine Herpes Virus, Equine Encephalomyelitis, Equine Influenza, West Nile Virus, Tetanus, and others. In 2023, musculoskeletal disorders and parasite control recorded the highest revenue, reflecting the prevalent health concerns among horses. However, the highest CAGR during the forecast period is expected in the Equine Herpes Virus and Equine Influenza segments, indicating a shifting landscape of health priorities in the equine community.

North America Remains the Global Leader

The equine healthcare market exhibits diverse geographic trends, with varying revenue contributions and CAGR across regions. North America emerged as the region with the highest revenue in 2023, driven by a well-established equine industry and a high level of awareness regarding equine healthcare. However, the region with the highest CAGR during the forecast period is anticipated to be Asia-Pacific, reflecting a growing interest in equine sports and recreation and an increasing focus on equine health in this region.

Market Competition to Intensify during the Forecast Period

The equine healthcare market features intense competition among key players, including Zoetis Inc., Boehringer Ingelheim, Merck & Co., Ceva, Sound, Hallmarq Veterinary Imaging, Esaote SPA, Vetoquinol S.A., IDEXX Laboratories, Inc., Dechra Pharmaceuticals PLC, and others. These companies employ strategies such as product innovation, collaborations, and acquisitions to strengthen their market position. In 2023, the total market revenues for these players were [provide actual revenue figures], with an expected increase during the forecast period from 2024 to 2032.

Historical & Forecast Period

This study report represents analysis of each segment from 2021 to 2031 considering 2022 as the base year. Compounded Annual Growth Rate (CAGR) for each of the respective segments estimated for the forecast period of 2023 to 2031.

The current report comprises of quantitative market estimations for each micro market for every geographical region and qualitative market analysis such as micro and macro environment analysis, market trends, competitive intelligence, segment analysis, porters five force model, top winning strategies, top investment markets, emerging trends and technological analysis, case studies, strategic conclusions and recommendations and other key market insights.

Research Methodology

The complete research study was conducted in three phases, namely: secondary research, primary research, and expert panel review. key data point that enables the estimation ofEquine Healthcare market are as follows:

  • Research and development budgets of manufacturers and government spending
  • Revenues of key companies in the market segment
  • Number of end users and consumption volume, price and value.

Geographical revenues generate by countries considered in the report:

Micro and macro environment factors that are currently influencing the Equine Healthcare market and their expected impact during the forecast period.

Market forecast was performed through proprietary software that analyzes various qualitative and quantitative factors. Growth rate and CAGR were estimated through intensive secondary and primary research. Data triangulation across various data points provides accuracy across various analyzed market segments in the report. Application of both top down and bottom-up approach for validation of market estimation assures logical, methodical and mathematical consistency of the quantitative data.

Market Segmentation

Product

    • Vaccines
    • Pharmaceuticals
  • Parasiticides
  • Anti-infectives
  • Anti-inflammatory & Analgesics
  • Other Pharmaceuticals
    • Medicinal Feed Additives
    • Diagnostics
    • Software & Services
    • Others

Indication

    • Musculoskeletal Disorders
    • Parasite Control
    • Internal Medicine
    • Equine Herpes Virus
    • Equine Encephalomyelitis
    • Equine Influenza
    • West Nile Virus
    • Tetanus
    • Others

Activity

    • Sports/Racing
    • Recreation
    • Others

Distribution Channel

    • Veterinary Hospitals & Clinics
    • E-commerce
    • Others

Region Segment (2021-2031; US$ Million)

  • North America
    • U.S.
    • Canada
    • Rest of North America
  • UK and European Union
    • UK
    • Germany
    • Spain
    • Italy
    • France
    • Rest of Europe
  • Asia Pacific
    • China
    • Japan
    • India
    • Australia
    • South Korea
    • Rest of Asia Pacific
  • Latin America
    • Brazil
    • Mexico
    • Rest of Latin America
  • Middle East and Africa
    • GCC
    • Africa
    • Rest of Middle East and Africa

Key questions answered in this report:

  • What are the key micro and macro environmental factors that are impacting the growth of Equine Healthcare market?
  • What are the key investment pockets with respect to product segments and geographies currently and during the forecast period?
  • Estimated forecast and market projections up to 2031.
  • Which segment accounts for the fastest CAGR during the forecast period?
  • Which market segment holds a larger market share and why?
  • Are low and middle-income economies investing in the Equine Healthcare market?
  • Which is the largest regional market for Equine Healthcare market?
  • What are the market trends and dynamics in emerging markets such as Asia Pacific, Latin America, and Middle East & Africa?
  • Which are the key trends driving Equine Healthcare market growth?
  • Who are the key competitors and what are their key strategies to enhance their market presence in the Equine Healthcare market worldwide?
Product Code: 138524-01-24

Table of Contents

1. Preface

  • 1.1. Report Description
    • 1.1.1. Purpose of the Report
    • 1.1.2. Target Audience
    • 1.1.3. Key Offerings
  • 1.2. Market Segmentation
  • 1.3. Research Methodology
    • 1.3.1. Phase I - Secondary Research
    • 1.3.2. Phase II - Primary Research
    • 1.3.3. Phase III - Expert Panel Review
    • 1.3.4. Assumptions
    • 1.3.5. Approach Adopted

2. Executive Summary

  • 2.1. Market Snapshot: Global Equine Healthcare Market
  • 2.2. Global Equine Healthcare Market, By Product, 2023 (US$ Million)
  • 2.3. Global Equine Healthcare Market, By Indication, 2023 (US$ Million)
  • 2.4. Global Equine Healthcare Market, By Activity, 2023 (US$ Million)
  • 2.5. Global Equine Healthcare Market, By Distribution Channel, 2023 (US$ Million)
  • 2.6. Global Equine Healthcare Market, By Geography, 2023 (US$ Million)
  • 2.7. Attractive Investment Proposition by Geography, 2023

3. Equine Healthcare Market: Competitive Analysis

  • 3.1. Market Positioning of Key Equine Healthcare Market Vendors
  • 3.2. Strategies Adopted by Equine Healthcare Market Vendors
  • 3.3. Key Industry Strategies
  • 3.4. Tier Analysis 2023 Versus 2032

4. Equine Healthcare Market: Macro Analysis & Market Dynamics

  • 4.1. Introduction
  • 4.2. Global Equine Healthcare Market Value, 2022 - 2032, (US$ Million)
  • 4.3. Market Dynamics
    • 4.3.1. Market Drivers
    • 4.3.2. Market Restraints
    • 4.3.3. Key Challenges
    • 4.3.4. Key Opportunities
  • 4.4. Impact Analysis of Drivers and Restraints
  • 4.5. See-Saw Analysis
  • 4.6. Porter's Five Force Model
    • 4.6.1. Supplier Power
    • 4.6.2. Buyer Power
    • 4.6.3. Threat Of Substitutes
    • 4.6.4. Threat Of New Entrants
    • 4.6.5. Competitive Rivalry
  • 4.7. PESTEL Analysis
    • 4.7.1. Political Landscape
    • 4.7.2. Economic Landscape
    • 4.7.3. Technology Landscape
    • 4.7.4. Legal Landscape
    • 4.7.5. Social Landscape

5. Equine Healthcare Market: By Product, 2022-2032, USD (Million)

  • 5.1. Market Overview
  • 5.2. Growth & Revenue Analysis: 2023 Versus 2032
  • 5.3. Volume and Pricing Analysis, 2022-2032
  • 5.4. Market Segmentation
    • 5.4.1. Vaccines
    • 5.4.2. Pharmaceuticals
      • 5.4.2.1. Parasiticides
      • 5.4.2.2. Anti-infectives
      • 5.4.2.3. Anti-inflammatory & Analgesics
      • 5.4.2.4. Other Pharmaceuticals
    • 5.4.3. Medicinal Feed Additives
    • 5.4.4. Diagnostics
    • 5.4.5. Software & Services
    • 5.4.6. Others

6. Equine Healthcare Market: By Indication, 2022-2032, USD (Million)

  • 6.1. Market Overview
  • 6.2. Growth & Revenue Analysis: 2023 Versus 2032
  • 6.3. Volume and Pricing Analysis, 2022-2032
  • 6.4. Market Segmentation
    • 6.4.1. Musculoskeletal Disorders
    • 6.4.2. Parasite Control
    • 6.4.3. Internal Medicine
    • 6.4.4. Equine Herpes Virus
    • 6.4.5. Equine Encephalomyelitis
    • 6.4.6. Equine Influenza
    • 6.4.7. West Nile Virus
    • 6.4.8. Tetanus
    • 6.4.9. Others

7. Equine Healthcare Market: By Activity, 2022-2032, USD (Million)

  • 7.1. Market Overview
  • 7.2. Growth & Revenue Analysis: 2023 Versus 2032
  • 7.3. Volume and Pricing Analysis, 2022-2032
  • 7.4. Market Segmentation
    • 7.4.1. Sports/Racing
    • 7.4.2. Recreation
    • 7.4.3. Others

8. Equine Healthcare Market: By Distribution Channel, 2022-2032, USD (Million)

  • 8.1. Market Overview
  • 8.2. Growth & Revenue Analysis: 2023 Versus 2032
  • 8.3. Volume and Pricing Analysis, 2022-2032
  • 8.4. Market Segmentation
    • 8.4.1. Veterinary Hospitals & Clinics
    • 8.4.2. E-commerce
    • 8.4.3. Others

9. North America Equine Healthcare Market, 2022-2032, USD (Million)

  • 9.1. Market Overview
  • 9.2. Equine Healthcare Market: By Product, 2022-2032, USD (Million)
  • 9.3. Equine Healthcare Market: By Indication, 2022-2032, USD (Million)
  • 9.4. Equine Healthcare Market: By Activity, 2022-2032, USD (Million)
  • 9.5. Equine Healthcare Market: By Distribution Channel, 2022-2032, USD (Million)
  • 9.6.Equine Healthcare Market: By Region, 2022-2032, USD (Million)
    • 9.6.1.North America
      • 9.6.1.1. U.S.
        • 9.6.1.1.1. Equine Healthcare Market: By Product, 2022-2032, USD (Million)
        • 9.6.1.1.2. Equine Healthcare Market: By Indication, 2022-2032, USD (Million)
        • 9.6.1.1.3. Equine Healthcare Market: By Activity, 2022-2032, USD (Million)
        • 9.6.1.1.4. Equine Healthcare Market: By Distribution Channel, 2022-2032, USD (Million)
      • 9.6.1.2. Canada
        • 9.6.1.2.1. Equine Healthcare Market: By Product, 2022-2032, USD (Million)
        • 9.6.1.2.2. Equine Healthcare Market: By Indication, 2022-2032, USD (Million)
        • 9.6.1.2.3. Equine Healthcare Market: By Activity, 2022-2032, USD (Million)
        • 9.6.1.2.4. Equine Healthcare Market: By Distribution Channel, 2022-2032, USD (Million)
      • 9.6.1.3. Rest of North America
        • 9.6.1.3.1. Equine Healthcare Market: By Product, 2022-2032, USD (Million)
        • 9.6.1.3.2. Equine Healthcare Market: By Indication, 2022-2032, USD (Million)
        • 9.6.1.3.3. Equine Healthcare Market: By Activity, 2022-2032, USD (Million)
        • 9.6.1.3.4. Equine Healthcare Market: By Distribution Channel, 2022-2032, USD (Million)

10. UK and European Union Equine Healthcare Market, 2022-2032, USD (Million)

  • 10.1. Market Overview
  • 10.2. Equine Healthcare Market: By Product, 2022-2032, USD (Million)
  • 10.3. Equine Healthcare Market: By Indication, 2022-2032, USD (Million)
  • 10.4. Equine Healthcare Market: By Activity, 2022-2032, USD (Million)
  • 10.5. Equine Healthcare Market: By Distribution Channel, 2022-2032, USD (Million)
  • 10.6.Equine Healthcare Market: By Region, 2022-2032, USD (Million)
    • 10.6.1.UK and European Union
      • 10.6.1.1. UK
        • 10.6.1.1.1. Equine Healthcare Market: By Product, 2022-2032, USD (Million)
        • 10.6.1.1.2. Equine Healthcare Market: By Indication, 2022-2032, USD (Million)
        • 10.6.1.1.3. Equine Healthcare Market: By Activity, 2022-2032, USD (Million)
        • 10.6.1.1.4. Equine Healthcare Market: By Distribution Channel, 2022-2032, USD (Million)
      • 10.6.1.2. Germany
        • 10.6.1.2.1. Equine Healthcare Market: By Product, 2022-2032, USD (Million)
        • 10.6.1.2.2. Equine Healthcare Market: By Indication, 2022-2032, USD (Million)
        • 10.6.1.2.3. Equine Healthcare Market: By Activity, 2022-2032, USD (Million)
        • 10.6.1.2.4. Equine Healthcare Market: By Distribution Channel, 2022-2032, USD (Million)
      • 10.6.1.3. Spain
        • 10.6.1.3.1. Equine Healthcare Market: By Product, 2022-2032, USD (Million)
        • 10.6.1.3.2. Equine Healthcare Market: By Indication, 2022-2032, USD (Million)
        • 10.6.1.3.3. Equine Healthcare Market: By Activity, 2022-2032, USD (Million)
        • 10.6.1.3.4. Equine Healthcare Market: By Distribution Channel, 2022-2032, USD (Million)
      • 10.6.1.4. Italy
        • 10.6.1.4.1. Equine Healthcare Market: By Product, 2022-2032, USD (Million)
        • 10.6.1.4.2. Equine Healthcare Market: By Indication, 2022-2032, USD (Million)
        • 10.6.1.4.3. Equine Healthcare Market: By Activity, 2022-2032, USD (Million)
        • 10.6.1.4.4. Equine Healthcare Market: By Distribution Channel, 2022-2032, USD (Million)
      • 10.6.1.5. France
        • 10.6.1.5.1. Equine Healthcare Market: By Product, 2022-2032, USD (Million)
        • 10.6.1.5.2. Equine Healthcare Market: By Indication, 2022-2032, USD (Million)
        • 10.6.1.5.3. Equine Healthcare Market: By Activity, 2022-2032, USD (Million)
        • 10.6.1.5.4. Equine Healthcare Market: By Distribution Channel, 2022-2032, USD (Million)
      • 10.6.1.6. Rest of Europe
        • 10.6.1.6.1. Equine Healthcare Market: By Product, 2022-2032, USD (Million)
        • 10.6.1.6.2. Equine Healthcare Market: By Indication, 2022-2032, USD (Million)
        • 10.6.1.6.3. Equine Healthcare Market: By Activity, 2022-2032, USD (Million)
        • 10.6.1.6.4. Equine Healthcare Market: By Distribution Channel, 2022-2032, USD (Million)

11. Asia Pacific Equine Healthcare Market, 2022-2032, USD (Million)

  • 11.1. Market Overview
  • 11.2. Equine Healthcare Market: By Product, 2022-2032, USD (Million)
  • 11.3. Equine Healthcare Market: By Indication, 2022-2032, USD (Million)
  • 11.4. Equine Healthcare Market: By Activity, 2022-2032, USD (Million)
  • 11.5. Equine Healthcare Market: By Distribution Channel, 2022-2032, USD (Million)
  • 11.6.Equine Healthcare Market: By Region, 2022-2032, USD (Million)
    • 11.6.1.Asia Pacific
      • 11.6.1.1. China
        • 11.6.1.1.1. Equine Healthcare Market: By Product, 2022-2032, USD (Million)
        • 11.6.1.1.2. Equine Healthcare Market: By Indication, 2022-2032, USD (Million)
        • 11.6.1.1.3. Equine Healthcare Market: By Activity, 2022-2032, USD (Million)
        • 11.6.1.1.4. Equine Healthcare Market: By Distribution Channel, 2022-2032, USD (Million)
      • 11.6.1.2. Japan
        • 11.6.1.2.1. Equine Healthcare Market: By Product, 2022-2032, USD (Million)
        • 11.6.1.2.2. Equine Healthcare Market: By Indication, 2022-2032, USD (Million)
        • 11.6.1.2.3. Equine Healthcare Market: By Activity, 2022-2032, USD (Million)
        • 11.6.1.2.4. Equine Healthcare Market: By Distribution Channel, 2022-2032, USD (Million)
      • 11.6.1.3. India
        • 11.6.1.3.1. Equine Healthcare Market: By Product, 2022-2032, USD (Million)
        • 11.6.1.3.2. Equine Healthcare Market: By Indication, 2022-2032, USD (Million)
        • 11.6.1.3.3. Equine Healthcare Market: By Activity, 2022-2032, USD (Million)
        • 11.6.1.3.4. Equine Healthcare Market: By Distribution Channel, 2022-2032, USD (Million)
      • 11.6.1.4. Australia
        • 11.6.1.4.1. Equine Healthcare Market: By Product, 2022-2032, USD (Million)
        • 11.6.1.4.2. Equine Healthcare Market: By Indication, 2022-2032, USD (Million)
        • 11.6.1.4.3. Equine Healthcare Market: By Activity, 2022-2032, USD (Million)
        • 11.6.1.4.4. Equine Healthcare Market: By Distribution Channel, 2022-2032, USD (Million)
      • 11.6.1.5. South Korea
        • 11.6.1.5.1. Equine Healthcare Market: By Product, 2022-2032, USD (Million)
        • 11.6.1.5.2. Equine Healthcare Market: By Indication, 2022-2032, USD (Million)
        • 11.6.1.5.3. Equine Healthcare Market: By Activity, 2022-2032, USD (Million)
        • 11.6.1.5.4. Equine Healthcare Market: By Distribution Channel, 2022-2032, USD (Million)
      • 11.6.1.6. Rest of Asia Pacific
        • 11.6.1.6.1. Equine Healthcare Market: By Product, 2022-2032, USD (Million)
        • 11.6.1.6.2. Equine Healthcare Market: By Indication, 2022-2032, USD (Million)
        • 11.6.1.6.3. Equine Healthcare Market: By Activity, 2022-2032, USD (Million)
        • 11.6.1.6.4. Equine Healthcare Market: By Distribution Channel, 2022-2032, USD (Million)

12. Latin America Equine Healthcare Market, 2022-2032, USD (Million)

  • 12.1. Market Overview
  • 12.2. Equine Healthcare Market: By Product, 2022-2032, USD (Million)
  • 12.3. Equine Healthcare Market: By Indication, 2022-2032, USD (Million)
  • 12.4. Equine Healthcare Market: By Activity, 2022-2032, USD (Million)
  • 12.5. Equine Healthcare Market: By Distribution Channel, 2022-2032, USD (Million)
  • 12.6.Equine Healthcare Market: By Region, 2022-2032, USD (Million)
    • 12.6.1.Latin America
      • 12.6.1.1. Brazil
        • 12.6.1.1.1. Equine Healthcare Market: By Product, 2022-2032, USD (Million)
        • 12.6.1.1.2. Equine Healthcare Market: By Indication, 2022-2032, USD (Million)
        • 12.6.1.1.3. Equine Healthcare Market: By Activity, 2022-2032, USD (Million)
        • 12.6.1.1.4. Equine Healthcare Market: By Distribution Channel, 2022-2032, USD (Million)
      • 12.6.1.2. Mexico
        • 12.6.1.2.1. Equine Healthcare Market: By Product, 2022-2032, USD (Million)
        • 12.6.1.2.2. Equine Healthcare Market: By Indication, 2022-2032, USD (Million)
        • 12.6.1.2.3. Equine Healthcare Market: By Activity, 2022-2032, USD (Million)
        • 12.6.1.2.4. Equine Healthcare Market: By Distribution Channel, 2022-2032, USD (Million)
      • 12.6.1.3. Rest of Latin America
        • 12.6.1.3.1. Equine Healthcare Market: By Product, 2022-2032, USD (Million)
        • 12.6.1.3.2. Equine Healthcare Market: By Indication, 2022-2032, USD (Million)
        • 12.6.1.3.3. Equine Healthcare Market: By Activity, 2022-2032, USD (Million)
        • 12.6.1.3.4. Equine Healthcare Market: By Distribution Channel, 2022-2032, USD (Million)

13. Middle East and Africa Equine Healthcare Market, 2022-2032, USD (Million)

  • 13.1. Market Overview
  • 13.2. Equine Healthcare Market: By Product, 2022-2032, USD (Million)
  • 13.3. Equine Healthcare Market: By Indication, 2022-2032, USD (Million)
  • 13.4. Equine Healthcare Market: By Activity, 2022-2032, USD (Million)
  • 13.5. Equine Healthcare Market: By Distribution Channel, 2022-2032, USD (Million)
  • 13.6.Equine Healthcare Market: By Region, 2022-2032, USD (Million)
    • 13.6.1.Middle East and Africa
      • 13.6.1.1. GCC
        • 13.6.1.1.1. Equine Healthcare Market: By Product, 2022-2032, USD (Million)
        • 13.6.1.1.2. Equine Healthcare Market: By Indication, 2022-2032, USD (Million)
        • 13.6.1.1.3. Equine Healthcare Market: By Activity, 2022-2032, USD (Million)
        • 13.6.1.1.4. Equine Healthcare Market: By Distribution Channel, 2022-2032, USD (Million)
      • 13.6.1.2. Africa
        • 13.6.1.2.1. Equine Healthcare Market: By Product, 2022-2032, USD (Million)
        • 13.6.1.2.2. Equine Healthcare Market: By Indication, 2022-2032, USD (Million)
        • 13.6.1.2.3. Equine Healthcare Market: By Activity, 2022-2032, USD (Million)
        • 13.6.1.2.4. Equine Healthcare Market: By Distribution Channel, 2022-2032, USD (Million)
      • 13.6.1.3. Rest of Middle East and Africa
        • 13.6.1.3.1. Equine Healthcare Market: By Product, 2022-2032, USD (Million)
        • 13.6.1.3.2. Equine Healthcare Market: By Indication, 2022-2032, USD (Million)
        • 13.6.1.3.3. Equine Healthcare Market: By Activity, 2022-2032, USD (Million)
        • 13.6.1.3.4. Equine Healthcare Market: By Distribution Channel, 2022-2032, USD (Million)

14. Company Profile

  • 14.1. Zoetis Inc.
    • 14.1.1. Company Overview
    • 14.1.2. Financial Performance
    • 14.1.3. Product Portfolio
    • 14.1.4. Strategic Initiatives
  • 14.2. Boehringer Ingelheim
    • 14.2.1. Company Overview
    • 14.2.2. Financial Performance
    • 14.2.3. Product Portfolio
    • 14.2.4. Strategic Initiatives
  • 14.3. Merck & Co.
    • 14.3.1. Company Overview
    • 14.3.2. Financial Performance
    • 14.3.3. Product Portfolio
    • 14.3.4. Strategic Initiatives
  • 14.4. Ceva
    • 14.4.1. Company Overview
    • 14.4.2. Financial Performance
    • 14.4.3. Product Portfolio
    • 14.4.4. Strategic Initiatives
  • 14.5. Sound
    • 14.5.1. Company Overview
    • 14.5.2. Financial Performance
    • 14.5.3. Product Portfolio
    • 14.5.4. Strategic Initiatives
  • 14.6. Hallmarq Veterinary Imaging
    • 14.6.1. Company Overview
    • 14.6.2. Financial Performance
    • 14.6.3. Product Portfolio
    • 14.6.4. Strategic Initiatives
  • 14.7. Esaote SPA
    • 14.7.1. Company Overview
    • 14.7.2. Financial Performance
    • 14.7.3. Product Portfolio
    • 14.7.4. Strategic Initiatives
  • 14.8. Vetoquinol S.A.
    • 14.8.1. Company Overview
    • 14.8.2. Financial Performance
    • 14.8.3. Product Portfolio
    • 14.8.4. Strategic Initiatives
  • 14.9. IDEXX Laboratories, Inc.
    • 14.9.1. Company Overview
    • 14.9.2. Financial Performance
    • 14.9.3. Product Portfolio
    • 14.9.4. Strategic Initiatives
  • 14.10. Dechra Pharmaceuticals PLC
    • 14.10.1. Company Overview
    • 14.10.2. Financial Performance
    • 14.10.3. Product Portfolio
    • 14.10.4. Strategic Initiatives
  • 14.11. Other Notable Players
    • 14.11.1. Company Overview
    • 14.11.2. Financial Performance
    • 14.11.3. Product Portfolio
    • 14.11.4. Strategic Initiatives
Product Code: 138524-01-24

List of Tables

  • TABLE 1 Global Equine Healthcare Market By Product, 2022-2032, USD (Million)
  • TABLE 2 Global Equine Healthcare Market By Pharmaceuticals, 2022-2032, USD (Million)

TABLE 3 Global Equine Healthcare Market By Indication, 2022-2032, USD (Million)

  • TABLE 4 Global Equine Healthcare Market By Activity, 2022-2032, USD (Million)
  • TABLE 5 Global Equine Healthcare Market By Distribution Channel, 2022-2032, USD (Million)
  • TABLE 6 North America Equine Healthcare Market By Product, 2022-2032, USD (Million)
  • TABLE 7 North America Equine Healthcare Market By Pharmaceuticals, 2022-2032, USD (Million)

TABLE 8 North America Equine Healthcare Market By Indication, 2022-2032, USD (Million)

  • TABLE 9 North America Equine Healthcare Market By Activity, 2022-2032, USD (Million)
  • TABLE 10 North America Equine Healthcare Market By Distribution Channel, 2022-2032, USD (Million)
  • TABLE 11 U.S. Equine Healthcare Market By Product, 2022-2032, USD (Million)
  • TABLE 12 U.S. Equine Healthcare Market By Pharmaceuticals, 2022-2032, USD (Million)

TABLE 13 U.S. Equine Healthcare Market By Indication, 2022-2032, USD (Million)

  • TABLE 14 U.S. Equine Healthcare Market By Activity, 2022-2032, USD (Million)
  • TABLE 15 U.S. Equine Healthcare Market By Distribution Channel, 2022-2032, USD (Million)
  • TABLE 16 Canada Equine Healthcare Market By Product, 2022-2032, USD (Million)
  • TABLE 17 Canada Equine Healthcare Market By Pharmaceuticals, 2022-2032, USD (Million)

TABLE 18 Canada Equine Healthcare Market By Indication, 2022-2032, USD (Million)

  • TABLE 19 Canada Equine Healthcare Market By Activity, 2022-2032, USD (Million)
  • TABLE 20 Canada Equine Healthcare Market By Distribution Channel, 2022-2032, USD (Million)
  • TABLE 21 Rest of North America Equine Healthcare Market By Product, 2022-2032, USD (Million)
  • TABLE 22 Rest of North America Equine Healthcare Market By Pharmaceuticals, 2022-2032, USD (Million)

TABLE 23 Rest of North America Equine Healthcare Market By Indication, 2022-2032, USD (Million)

  • TABLE 24 Rest of North America Equine Healthcare Market By Activity, 2022-2032, USD (Million)
  • TABLE 25 Rest of North America Equine Healthcare Market By Distribution Channel, 2022-2032, USD (Million)
  • TABLE 26 UK and European Union Equine Healthcare Market By Product, 2022-2032, USD (Million)
  • TABLE 27 UK and European Union Equine Healthcare Market By Pharmaceuticals, 2022-2032, USD (Million)

TABLE 28 UK and European Union Equine Healthcare Market By Indication, 2022-2032, USD (Million)

  • TABLE 29 UK and European Union Equine Healthcare Market By Activity, 2022-2032, USD (Million)
  • TABLE 30 UK and European Union Equine Healthcare Market By Distribution Channel, 2022-2032, USD (Million)
  • TABLE 31 UK Equine Healthcare Market By Product, 2022-2032, USD (Million)
  • TABLE 32 UK Equine Healthcare Market By Pharmaceuticals, 2022-2032, USD (Million)

TABLE 33 UK Equine Healthcare Market By Indication, 2022-2032, USD (Million)

  • TABLE 34 UK Equine Healthcare Market By Activity, 2022-2032, USD (Million)
  • TABLE 35 UK Equine Healthcare Market By Distribution Channel, 2022-2032, USD (Million)
  • TABLE 36 Germany Equine Healthcare Market By Product, 2022-2032, USD (Million)
  • TABLE 37 Germany Equine Healthcare Market By Pharmaceuticals, 2022-2032, USD (Million)

TABLE 38 Germany Equine Healthcare Market By Indication, 2022-2032, USD (Million)

  • TABLE 39 Germany Equine Healthcare Market By Activity, 2022-2032, USD (Million)
  • TABLE 40 Germany Equine Healthcare Market By Distribution Channel, 2022-2032, USD (Million)
  • TABLE 41 Spain Equine Healthcare Market By Product, 2022-2032, USD (Million)
  • TABLE 42 Spain Equine Healthcare Market By Pharmaceuticals, 2022-2032, USD (Million)

TABLE 43 Spain Equine Healthcare Market By Indication, 2022-2032, USD (Million)

  • TABLE 44 Spain Equine Healthcare Market By Activity, 2022-2032, USD (Million)
  • TABLE 45 Spain Equine Healthcare Market By Distribution Channel, 2022-2032, USD (Million)
  • TABLE 46 Italy Equine Healthcare Market By Product, 2022-2032, USD (Million)
  • TABLE 47 Italy Equine Healthcare Market By Pharmaceuticals, 2022-2032, USD (Million)

TABLE 48 Italy Equine Healthcare Market By Indication, 2022-2032, USD (Million)

  • TABLE 49 Italy Equine Healthcare Market By Activity, 2022-2032, USD (Million)
  • TABLE 50 Italy Equine Healthcare Market By Distribution Channel, 2022-2032, USD (Million)
  • TABLE 51 France Equine Healthcare Market By Product, 2022-2032, USD (Million)
  • TABLE 52 France Equine Healthcare Market By Pharmaceuticals, 2022-2032, USD (Million)

TABLE 53 France Equine Healthcare Market By Indication, 2022-2032, USD (Million)

  • TABLE 54 France Equine Healthcare Market By Activity, 2022-2032, USD (Million)
  • TABLE 55 France Equine Healthcare Market By Distribution Channel, 2022-2032, USD (Million)
  • TABLE 56 Rest of Europe Equine Healthcare Market By Product, 2022-2032, USD (Million)
  • TABLE 57 Rest of Europe Equine Healthcare Market By Pharmaceuticals, 2022-2032, USD (Million)

TABLE 58 Rest of Europe Equine Healthcare Market By Indication, 2022-2032, USD (Million)

  • TABLE 59 Rest of Europe Equine Healthcare Market By Activity, 2022-2032, USD (Million)
  • TABLE 60 Rest of Europe Equine Healthcare Market By Distribution Channel, 2022-2032, USD (Million)
  • TABLE 61 Asia Equine Healthcare Market By Product, 2022-2032, USD (Million)
  • TABLE 62 Asia Equine Healthcare Market By Pharmaceuticals, 2022-2032, USD (Million)

TABLE 63 Asia Equine Healthcare Market By Indication, 2022-2032, USD (Million)

  • TABLE 64 Asia Equine Healthcare Market By Activity, 2022-2032, USD (Million)
  • TABLE 65 Asia Equine Healthcare Market By Distribution Channel, 2022-2032, USD (Million)
  • TABLE 66 China Equine Healthcare Market By Product, 2022-2032, USD (Million)
  • TABLE 67 China Equine Healthcare Market By Pharmaceuticals, 2022-2032, USD (Million)

TABLE 68 China Equine Healthcare Market By Indication, 2022-2032, USD (Million)

  • TABLE 69 China Equine Healthcare Market By Activity, 2022-2032, USD (Million)
  • TABLE 70 China Equine Healthcare Market By Distribution Channel, 2022-2032, USD (Million)
  • TABLE 71 Japan Equine Healthcare Market By Product, 2022-2032, USD (Million)
  • TABLE 72 Japan Equine Healthcare Market By Pharmaceuticals, 2022-2032, USD (Million)

TABLE 73 Japan Equine Healthcare Market By Indication, 2022-2032, USD (Million)

  • TABLE 74 Japan Equine Healthcare Market By Activity, 2022-2032, USD (Million)
  • TABLE 75 Japan Equine Healthcare Market By Distribution Channel, 2022-2032, USD (Million)
  • TABLE 76 India Equine Healthcare Market By Product, 2022-2032, USD (Million)
  • TABLE 77 India Equine Healthcare Market By Pharmaceuticals, 2022-2032, USD (Million)

TABLE 78 India Equine Healthcare Market By Indication, 2022-2032, USD (Million)

  • TABLE 79 India Equine Healthcare Market By Activity, 2022-2032, USD (Million)
  • TABLE 80 India Equine Healthcare Market By Distribution Channel, 2022-2032, USD (Million)
  • TABLE 81 Australia Equine Healthcare Market By Product, 2022-2032, USD (Million)
  • TABLE 82 Australia Equine Healthcare Market By Pharmaceuticals, 2022-2032, USD (Million)

TABLE 83 Australia Equine Healthcare Market By Indication, 2022-2032, USD (Million)

  • TABLE 84 Australia Equine Healthcare Market By Activity, 2022-2032, USD (Million)
  • TABLE 85 Australia Equine Healthcare Market By Distribution Channel, 2022-2032, USD (Million)
  • TABLE 86 South Korea Equine Healthcare Market By Product, 2022-2032, USD (Million)
  • TABLE 87 South Korea Equine Healthcare Market By Pharmaceuticals, 2022-2032, USD (Million)

TABLE 88 South Korea Equine Healthcare Market By Indication, 2022-2032, USD (Million)

  • TABLE 89 South Korea Equine Healthcare Market By Activity, 2022-2032, USD (Million)
  • TABLE 90 South Korea Equine Healthcare Market By Distribution Channel, 2022-2032, USD (Million)
  • TABLE 91 Latin America Equine Healthcare Market By Product, 2022-2032, USD (Million)
  • TABLE 92 Latin America Equine Healthcare Market By Pharmaceuticals, 2022-2032, USD (Million)

TABLE 93 Latin America Equine Healthcare Market By Indication, 2022-2032, USD (Million)

  • TABLE 94 Latin America Equine Healthcare Market By Activity, 2022-2032, USD (Million)
  • TABLE 95 Latin America Equine Healthcare Market By Distribution Channel, 2022-2032, USD (Million)
  • TABLE 96 Brazil Equine Healthcare Market By Product, 2022-2032, USD (Million)
  • TABLE 97 Brazil Equine Healthcare Market By Pharmaceuticals, 2022-2032, USD (Million)

TABLE 98 Brazil Equine Healthcare Market By Indication, 2022-2032, USD (Million)

  • TABLE 99 Brazil Equine Healthcare Market By Activity, 2022-2032, USD (Million)
  • TABLE 100 Brazil Equine Healthcare Market By Distribution Channel, 2022-2032, USD (Million)
  • TABLE 101 Mexico Equine Healthcare Market By Product, 2022-2032, USD (Million)
  • TABLE 102 Mexico Equine Healthcare Market By Pharmaceuticals, 2022-2032, USD (Million)

TABLE 103 Mexico Equine Healthcare Market By Indication, 2022-2032, USD (Million)

  • TABLE 104 Mexico Equine Healthcare Market By Activity, 2022-2032, USD (Million)
  • TABLE 105 Mexico Equine Healthcare Market By Distribution Channel, 2022-2032, USD (Million)
  • TABLE 106 Rest of Latin America Equine Healthcare Market By Product, 2022-2032, USD (Million)
  • TABLE 107 Rest of Latin America Equine Healthcare Market By Pharmaceuticals, 2022-2032, USD (Million)

TABLE 108 Rest of Latin America Equine Healthcare Market By Indication, 2022-2032, USD (Million)

  • TABLE 109 Rest of Latin America Equine Healthcare Market By Activity, 2022-2032, USD (Million)
  • TABLE 110 Rest of Latin America Equine Healthcare Market By Distribution Channel, 2022-2032, USD (Million)
  • TABLE 111 Middle East and Africa Equine Healthcare Market By Product, 2022-2032, USD (Million)
  • TABLE 112 Middle East and Africa Equine Healthcare Market By Pharmaceuticals, 2022-2032, USD (Million)

TABLE 113 Middle East and Africa Equine Healthcare Market By Indication, 2022-2032, USD (Million)

  • TABLE 114 Middle East and Africa Equine Healthcare Market By Activity, 2022-2032, USD (Million)
  • TABLE 115 Middle East and Africa Equine Healthcare Market By Distribution Channel, 2022-2032, USD (Million)
  • TABLE 116 GCC Equine Healthcare Market By Product, 2022-2032, USD (Million)
  • TABLE 117 GCC Equine Healthcare Market By Pharmaceuticals, 2022-2032, USD (Million)

TABLE 118 GCC Equine Healthcare Market By Indication, 2022-2032, USD (Million)

  • TABLE 119 GCC Equine Healthcare Market By Activity, 2022-2032, USD (Million)
  • TABLE 120 GCC Equine Healthcare Market By Distribution Channel, 2022-2032, USD (Million)
  • TABLE 121 Africa Equine Healthcare Market By Product, 2022-2032, USD (Million)
  • TABLE 122 Africa Equine Healthcare Market By Pharmaceuticals, 2022-2032, USD (Million)

TABLE 123 Africa Equine Healthcare Market By Indication, 2022-2032, USD (Million)

  • TABLE 124 Africa Equine Healthcare Market By Activity, 2022-2032, USD (Million)
  • TABLE 125 Africa Equine Healthcare Market By Distribution Channel, 2022-2032, USD (Million)
  • TABLE 126 Rest of Middle East and Africa Equine Healthcare Market By Product, 2022-2032, USD (Million)
  • TABLE 127 Rest of Middle East and Africa Equine Healthcare Market By Pharmaceuticals, 2022-2032, USD (Million)

TABLE 128 Rest of Middle East and Africa Equine Healthcare Market By Indication, 2022-2032, USD (Million)

  • TABLE 129 Rest of Middle East and Africa Equine Healthcare Market By Activity, 2022-2032, USD (Million)
  • TABLE 130 Rest of Middle East and Africa Equine Healthcare Market By Distribution Channel, 2022-2032, USD (Million)

List of Figures

  • FIG. 1 Global Equine Healthcare Market: Market Coverage
  • FIG. 2 Research Methodology and Data Sources
  • FIG. 3 Market Size Estimation - Top Down & Bottom-Up Approach
  • FIG. 4 Global Equine Healthcare Market: Quality Assurance
  • FIG. 5 Global Equine Healthcare Market, By Product, 2023
  • FIG. 6 Global Equine Healthcare Market, By Indication, 2023
  • FIG. 7 Global Equine Healthcare Market, By Activity, 2023
  • FIG. 8 Global Equine Healthcare Market, By Distribution Channel, 2023
  • FIG. 9 Global Equine Healthcare Market, By Geography, 2023
  • FIG. 10 Market Geographical Opportunity Matrix - Global Equine Healthcare Market, 2023

FIG. 11Market Positioning of Key Equine Healthcare Market Players, 2023

FIG. 12Global Equine Healthcare Market - Tier Analysis - Percentage of Revenues by Tier Level, 2023 Versus 2032

  • FIG. 13 Global Equine Healthcare Market, By Product, 2023 Vs 2032, %
  • FIG. 14 Global Equine Healthcare Market, By Indication, 2023 Vs 2032, %
  • FIG. 15 Global Equine Healthcare Market, By Activity, 2023 Vs 2032, %
  • FIG. 16 Global Equine Healthcare Market, By Distribution Channel, 2023 Vs 2032, %
  • FIG. 17 U.S. Equine Healthcare Market (US$ Million), 2022 - 2032
  • FIG. 18 Canada Equine Healthcare Market (US$ Million), 2022 - 2032
  • FIG. 19 Rest of North America Equine Healthcare Market (US$ Million), 2022 - 2032
  • FIG. 20 UK Equine Healthcare Market (US$ Million), 2022 - 2032
  • FIG. 21 Germany Equine Healthcare Market (US$ Million), 2022 - 2032
  • FIG. 22 Spain Equine Healthcare Market (US$ Million), 2022 - 2032
  • FIG. 23 Italy Equine Healthcare Market (US$ Million), 2022 - 2032
  • FIG. 24 France Equine Healthcare Market (US$ Million), 2022 - 2032
  • FIG. 25 Rest of Europe Equine Healthcare Market (US$ Million), 2022 - 2032
  • FIG. 26 China Equine Healthcare Market (US$ Million), 2022 - 2032
  • FIG. 27 Japan Equine Healthcare Market (US$ Million), 2022 - 2032
  • FIG. 28 India Equine Healthcare Market (US$ Million), 2022 - 2032
  • FIG. 29 Australia Equine Healthcare Market (US$ Million), 2022 - 2032
  • FIG. 30 South Korea Equine Healthcare Market (US$ Million), 2022 - 2032
  • FIG. 31 Rest of Asia Equine Healthcare Market (US$ Million), 2022 - 2032
  • FIG. 32 Brazil Equine Healthcare Market (US$ Million), 2022 - 2032
  • FIG. 33 Mexico Equine Healthcare Market (US$ Million), 2022 - 2032
  • FIG. 34 Rest of Latin America Equine Healthcare Market (US$ Million), 2022 - 2032
  • FIG. 35 GCC Equine Healthcare Market (US$ Million), 2022 - 2032
  • FIG. 36 Africa Equine Healthcare Market (US$ Million), 2022 - 2032
  • FIG. 37 Rest of Middle East and Africa Equine Healthcare Market (US$ Million), 2022 - 2032
Have a question?
Picture

Jeroen Van Heghe

Manager - EMEA

+32-2-535-7543

Picture

Christine Sirois

Manager - Americas

+1-860-674-8796

Questions? Please give us a call or visit the contact form.
Hi, how can we help?
Contact us!